版本:
中国

BRIEF-Windtree Therapeutics reports Q4 loss per share $0.77

March 31 Windtree Therapeutics Inc

* Windtree Therapeutics reports fourth quarter 2016 financial results and provides key business updates

* Q4 loss per share $0.77

* Q4 revenue $900,000 versus $700,000

* Windtree Therapeutics-existing cash resources sufficient to fund operations through completion of aerosurf phase 2b clinical trial,results in mid-2017 Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐